AGORÀ UP TO DATE 2026: Scientific Update and New Perspectives in Aesthetic Medicine

On April 11, 2026, at Monterosa 91 in Milan, Agorà Up To Date 2026 took place — a scientific update day dedicated to physician members of the Società Italiana di Medicina ad Indirizzo Estetico – Agorà, organized with the support of the Society's Focus Groups.

The event provided an intensive educational forum integrating the latest scientific evidence with clinical experience sharing, interactive discussion, and real case presentations.

The day opened with an institutional address by Dott. Ugo Giovanni Tamborini, Secretary of the Ordine dei Medici Chirurghi ed Odontoiatri of the Province of Milan, whose participation underscored the institutional recognition of the Society's scientific and educational mission.

During the opening session, the Agorà Scientific Society presented a Certificate of Recognition to Prof. Franz Wilhelm Baruffaldi Preis, in acknowledgment of his exceptional dedication and clinical leadership in directing the Burns Center of the Ospedale Niguarda in the care of victims of the Crans-Montana fire (January 1, 2026) — transforming one of the most devastating tragedies of recent decades into a collective act of hope.

REGENERATIVE MEDICINE

Maurizio Cavallini presented the state of the art in regenerative aesthetic medicine, a rapidly evolving field still characterized by significant methodological heterogeneity. The main approaches under review — PRP, polynucleotides, exosomes, and biomaterials — share common biological mechanisms, including fibroblast stimulation and collagen synthesis induction, but require greater standardization and more robust clinical evidence for full integration into daily practice. The session included a literature update and clinical case presentations supporting the translation of evidence into the outpatient setting.

DERMOCOSMETICS

Magda Belmontesi, Eleonora Talerico, and Francesca Villa presented the results of the "Dermocosmetics" Focus Group, highlighting the role of dermocosmetics as a clinical tool in barrier function modulation, support of aesthetic medical treatments, and recovery time optimization. The session also introduced a project currently under development: the definition of an Agorà basic dermocosmetic protocol, aimed at providing members with a standardized, evidence-based operational tool.

INJECTABLE TREATMENTS OF THE FACE

Patrizia Piersini examined the "Ozempic face" phenomenon, associated with the use of GLP-1 receptor agonists. The rapid weight loss induced by these drugs leads to a reduction in facial adipose volumes with consequent acceleration of aging signs, requiring a multimodal therapeutic approach. The effects on facial tissue quality and their impact on clinical protocols were analyzed, supported by illustrative case presentations and discussion of possible corrective strategies.

BOTULINUM TOXIN

Monica Renga conducted an interactive educational session in collaboration between the "Botulinum Toxin" Focus Group and the "Restorative Medicine" Focus Group. Analysis of a complex clinical case of post-facial palsy asymmetry — presented through real photographic images and anatomical atlas plates — enabled the shared identification of the muscles involved and discussion of therapeutic strategies through interactive in-room voting.

SHARED RECOMMENDATIONS ON COMPLICATION MANAGEMENT

This clinically-oriented session in collaboration with SIME – Società Italiana di Medicina Estetica addressed complication management through case report presentations and discussion of shared recommendations. Marco Papagni proposed a critical analysis of the operational implications. Andrea Cordovana addressed rhinofiller complications, emphasizing that vascular risk, despite a low incidence of serious events, requires specific expertise and structured prevention protocols. Gloria Trocchi discussed delayed complications, and Alessia Viscardi addressed vascular complications.

LASER AND ENERGY-BASED DEVICES

Riccardo Lazzari presented a selection of representative clinical cases illustrating the use of lasers and energy-based devices in aesthetic medicine, with discussion of indications, technological limitations, and treatment selection criteria. The session provided an opportunity to analyze complex clinical scenarios that may require the use of this group of technologies, fostering direct discussion among participants.

MEDICAL GASES

Andrea Cordovana illustrated the emerging applications of medical gases in aesthetic medicine, with reference to improvements in microcirculation, tissue oxygenation, and regenerative processes. Available evidence from the literature was discussed in relation to clinical development perspectives, supported by cases applied to the outpatient setting.

COMPLICANZE

Marco Papagni presented the results of a narrative review on the use of hyaluronidase in aesthetic medicine, analyzing available formulations, safety profile, and clinical practice implications. Evidence relating to immunological testing and decision-making algorithms was evaluated, integrated with clinical case presentations for outpatient complication management.

ULTRASOUND LAB

The practical session, led by Stefania Belletti, Alessandra Ferla Lodigiani, and Marco Papagni, examined the growing role of ultrasound in aesthetic medicine as a diagnostic tool, procedural guide, and support in complication management. Demonstrations focused on ultrasound evaluation of the main facial structures, with the aim of developing operational skills immediately applicable in clinical practice.

Agorà Up To Date 2026 confirmed the trajectory of an increasingly integrated, scientific, and evidence-oriented aesthetic medicine. The day represented an opportunity for structured scientific update and peer exchange, in line with the Society's educational mission and its commitment to transferring skills directly applicable to daily clinical practice.